Breast reconstruction after mastectomy: which approach leads to happier patients?
NCT ID NCT07699913
First seen Jul 13, 2026 · Last updated Jul 16, 2026 · Updated 3 times
Summary
This study looks at how different types of bilateral breast reconstruction affect women's quality of life and satisfaction. Researchers will compare women who had preventive mastectomy (due to high risk) with those who had therapeutic mastectomy (due to cancer), and also consider the timing and type of reconstruction. Participants fill out the BREAST-Q questionnaire to measure their well-being and satisfaction starting three months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help surgeons and patients choose the best reconstruction approach to improve long-term well-being.
- What could go wrong
- As an observational study, it cannot prove cause and effect. Results may not apply to all patients or reconstruction methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 115 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients treated at CHU Grenoble Alpes for bilateral breast reconstruction between January 1, 2015, and January 1, 2026, in the plastic surgery and gynecology departments (departments performing breast reconstruction procedures).
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female sex * Age ≥ 18 years * Bilateral mastectomy * Breast reconstruction between January 1, 2015, and January 1, 2026 * No objection to the study Exclusion Criteria: * Individual under guardianship or curatorship, or deprived of liberty * Reconstruction not completed by January 1, 2026.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Retrospective analysis of pyrotinib in the treatment of HER2-Positive advanced breast cancer previously treated with trastuzumab and pertuzumab
- Mind and body: does resilience leave a molecular mark in breast cancer?
- Which pain block works better for breast surgery?
- Can a Triple-Drug combo erase HER2-Positive breast tumors before surgery?
- Bacteria inside tumors may hold the key to breast cancer treatment
- Can a newer drug ease the bone pain of chemotherapy support?